Loraz and Multiple sclerosis aggravated - a phase IV clinical study of FDA data
Summary:
Multiple sclerosis aggravated is reported as a side effect among people who take Loraz (lorazepam), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Baclofen, and have Pain.
The phase IV clinical study analyzes which people have Multiple sclerosis aggravated when taking Loraz. It is created by eHealthMe based on reports of 161,700 people who have side effects when taking Loraz from the FDA, and is updated regularly.
What is Loraz?
Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,695 Loraz users. Check the latest studies of Loraz.
What is Multiple sclerosis aggravated?
Multiple sclerosis aggravated (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,023 drugs and 323 conditions by eHealthMe. Check the latest studies of Multiple sclerosis aggravated.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
161,700 people reported to have side effects when taking Loraz.
Among them, 310 people (0.19%) have Multiple sclerosis aggravated.
Among these 310 people:
How long have people been on Loraz when they have Multiple sclerosis aggravated? *
What is the gender of people who have Multiple sclerosis aggravated when taking Loraz? *
What is the age of people who have Multiple sclerosis aggravated when taking Loraz? *
What are other drugs people take besides Loraz? *
What are other side effects people have besides Multiple sclerosis aggravated? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Loraz and have Multiple sclerosis aggravated?
- Check whether Multiple sclerosis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Loraz:
- Loraz (165,695 reports)
Multiple sclerosis aggravated treatments and more:
- Multiple sclerosis aggravated (1,779 reports)
How severe was Multiple sclerosis aggravated and when was it recovered:
Expand to all the drugs that have ingredients of lorazepam:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Loraz:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Multiple sclerosis aggravated:
- Multiple sclerosis aggravated (1,023 drugs)
Browse all the conditions that are associated with Multiple sclerosis aggravated:
- Multiple sclerosis aggravated (323 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lorazepam (the active ingredients of Loraz) and Loraz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Norvasc and Gastroesophageal Reflux Disease for Women aged 30-39 - 2 seconds ago
- Norvasc and Gastrooesophageal Reflux Disease for Women aged 30-39 - 2 seconds ago
- Norvasc and Gastro-Oesophageal Reflux Disease for Women aged 30-39 - 2 seconds ago
- Norvasc and Reflux for Women aged 30-39 - 2 seconds ago
- Norvasc and Heartburn for Women aged 30-39 - 3 seconds ago
- Norvasc and Non-Cardiac Chest Pain for Women aged 30-39 - 3 seconds ago
- Norvasc and Gerds for Women aged 30-39 - 3 seconds ago
- Norvasc and Acid Reflux for Women aged 30-39 - 4 seconds ago
- Norvasc and Reflux Esophagitis for Women aged 30-39 - 4 seconds ago
- Norvasc and Peptic Esophagitis for Women aged 30-39 - 4 seconds ago